Hologic Hologic Obtains CE Mark for Molecular Epstein-Barr, BK Virus Assays The EBV and BK virus tests, the first quantitative assays developed for the Panther Fusion system, expand Hologic’s transplant pathogen monitoring menu. Hologic Nabs FDA Approval for Quantitative Cytomegalovirus Test The test runs on Hologic's Panther system and is intended to be used for post-transplant pathogen detection and monitoring. ASCO Guideline Update Expands, Clarifies Use of Breast Cancer Adjuvant Treatment Test The update incorporates recent evidence on test performance in different categories of patients based on age, menopausal status, and lymph node positivity. Hologic Q2 Revenues Drop 7 Percent on Lower COVID-19 Assay Sales Within diagnostics, the company said its molecular diagnostics revenues were $862.5 million, down 8 percent from $935.3 million in Q2 2021. As COVID-19 Sales Retreat, Diagnostic Firms Turn Attention to Core Businesses Premium Many firms that had switched to COVID-19 testing throughout the pandemic as demand soared are now reevaluating their business strategies. Apr 4, 2022 Evercore ISI Downgrades Hologic to In-Line Rating Feb 2, 2022 Hologic Fiscal Q1 Revenues Fall 9 Percent as COVID-19 Assay Sales Decline Jan 12, 2022 JPM Healthcare Conference Day 2: Thermo Fisher, BD, SomaLogic, Myriad, Oxford Nanopore, More Jan 10, 2022 Hologic Preliminary Fiscal Q1 Revenues Drop 9 Percent Dec 23, 2021 New Products Posted to GenomeWeb: Hologic, Twist Bioscience, AusDiagnostics, More Nov 2, 2021 Hologic Expects Strong Future Revenue Growth Despite Q4 Decline, 'Regardless of How COVID Evolves' Premium Nov 1, 2021 Hologic Fiscal Q4 Revenues Fall 2 Percent on Lower COVID-19 Assay Sales Oct 4, 2021 STIs Reached Record Highs, Then COVID-19 Hit. Test Makers Now Ponder What's Next Premium Sep 24, 2021 People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More Jul 29, 2021 Hologic Strategic Plan Points to Long-Term Revenue Growth Driven by MDx Platforms, Tests Premium Jul 28, 2021 Hologic Q3 Revenues Rise 42 Percent Despite Lower Demand for SARS-CoV-2 MDx Assays Jul 14, 2021 Hologic Obtains CE Mark for Use of Saliva With SARS-CoV-2 Molecular Test Jul 6, 2021 Hologic Upgraded to Outperform by Evercore ISI Jun 23, 2021 Hologic Receives CE Mark for Molecular Test to Quantify Cytomegalovirus May 10, 2021 Medicare Expands Coverage for Hologic's Biotheranostics Breast Cancer Test May 5, 2021 US Department of Defense Awards $178.5M Contract to Hologic for SARS-CoV-2 Assays, Multiplex Tests Apr 30, 2021 Hologic Banking on MDx Acquisitions to Elevate Long-Term Revenue Growth Premium Apr 28, 2021 Hologic Q2 Revenues Climb 104 Percent on Continued COVID-19 Demand, Recovery of Base Businesses Apr 8, 2021 Hologic to Acquire Finnish MDx Firm Mobidiag for Approximately $795M Mar 8, 2021 With Diagenode Acquisition, Hologic Expects to Expand Panther Fusion Testing Menu Premium Load More Breaking News Canadian Healthcare Providers, Policymakers Value Different Aspects of Clinical Genomic Sequencing New Products Posted to GenomeWeb: Oxford Nanopore, Bio-Rad, NanoString, More People in the News at OraSure, Element Biosciences, Micronoma, More Guardant Health Files Motions to Dismiss, Change Venue in Illumina Patent Lawsuit In Brief This Week: SQI Diagnostics, T2 Biosystems, Enhanc3D, QuidelOrtho, More Illumina, Precision Health Research Singapore Partner for 100K Genomes Population Study The Scan Blend of Omicron With Delta The Associated Press reports that currently circulating Omicron variants have some features previously seen in the Delta variant. Limited Contrast The New York Times reports that there is a shortage of a contrast agent used for some medical scans. Pig Improvement Farmers in China are using genetics to improve their hog herds, according to Reuters. Science Papers Present Way to Molecularly Classify Prostate Cancer, Saliva-Based SARS-CoV-2 Test, More In Science this week: approach to molecularly classify prostate tumors, saliva-based test for SARS-CoV-2, and more.